当前位置:首页 - 行情中心 - 海创药业-U(688302) - 财务分析 - 现金流量表

海创药业-U

(688302)

  

流通市值:45.45亿  总市值:45.45亿
流通股本:9901.56万   总股本:9901.56万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金27,001,460.0525,743,692.3519,840,149.5713,016,290
  收到其他与经营活动有关的现金21,577,545.5645,187,361.1134,656,225.6225,983,333.78
  经营活动现金流入小计48,579,005.6170,931,053.4654,496,375.1938,999,623.78
  购买商品、接受劳务支付的现金2,133,748.733,914,602.353,111,340.432,152,824.82
  支付给职工以及为职工支付的现金27,528,085.473,048,754.957,199,710.1837,333,856.04
  支付的各项税费52,873.741,115,591.57588,066.12507,824.61
  支付其他与经营活动有关的现金29,992,283.27101,730,393.1273,306,230.3646,433,160.18
  经营活动现金流出小计59,706,991.14179,809,341.94134,205,347.0986,427,665.65
  经营活动产生的现金流量净额-11,127,985.53-108,878,288.48-79,708,971.9-47,428,041.87
二、投资活动产生的现金流量:
  收回投资收到的现金540,000,0002,485,050,0001,870,050,0001,300,050,000
  取得投资收益收到的现金1,411,298.648,441,969.135,940,964.774,064,380.13
  处置固定资产、无形资产和其他长期资产收回的现金净额718147.38147.38-
  收到的其他与投资活动有关的现金-34,740,340.3241,397,341.6334,740,430.66
  投资活动现金流入小计541,412,016.642,528,232,456.831,917,388,453.781,338,854,810.79
  购建固定资产、无形资产和其他长期资产支付的现金8,234,114.7982,886,135.8157,314,600.6741,503,612.8
  投资支付的现金520,000,0002,585,050,0002,070,050,0001,310,050,000
  支付其他与投资活动有关的现金--8,698,614.48,698,614.4
  投资活动现金流出小计528,234,114.792,667,936,135.812,136,063,215.071,360,252,227.2
  投资活动产生的现金流量净额13,177,901.85-139,703,678.98-218,674,761.29-21,397,416.41
三、筹资活动产生的现金流量:
  取得借款收到的现金-100,000,000100,000,000100,000,000
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-100,000,000100,000,000100,000,000
  分配股利、利润或偿付利息支付的现金642,5001,242,166.67592,527.78-
  支付其他与筹资活动有关的现金965,131.363,517,163.032,763,637.471,842,424.98
  筹资活动现金流出小计1,607,631.364,759,329.73,356,165.251,842,424.98
  筹资活动产生的现金流量净额-1,607,631.3695,240,670.396,643,834.7598,157,575.02
四、汇率变动对现金及现金等价物的影响-1,698,760.99-2,294,393.72-1,084,227.63-339,461.45
五、现金及现金等价物净增加额-1,256,476.03-155,635,690.88-202,824,126.0728,992,655.29
  加:期初现金及现金等价物余额437,590,365.61593,226,056.49593,226,056.49593,226,056.49
  期末现金及现金等价物余额436,333,889.58437,590,365.61390,401,930.42622,218,711.78
补充资料:
  净利润--137,252,611.25--61,853,200.96
  固定资产和投资性房地产折旧-3,523,342.55-1,392,215.42
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-3,523,342.55-1,392,215.42
  无形资产摊销-695,059.88--
  公允价值变动损失--10,167,088.15--2,054,220.43
  财务费用--451,501.07--956,367.24
  投资损失--5,184,084.25--1,843,351.3
  存货的减少--2,840,989.8--1,048,631.03
  经营性应收项目的减少-1,349,150.68--6,598,876.25
  经营性应付项目的增加-28,994,973.13-16,164,333.26
  其他-8,683,522.9-7,029,599.25
  现金的期末余额-437,590,365.61-622,218,711.78
  减:现金的期初余额-593,226,056.49-593,226,056.49
  现金及现金等价物的净增加额--155,635,690.88-28,992,655.29
公告日期2026-04-252026-04-252025-10-312025-08-14
审计意见(境内)标准无保留意见
TOP↑